The risk of immune-mediated skin disease under dipeptidyl-peptidase IV inhibitor: A global population-based study

Published: 3 June 2025| Version 1 | DOI: 10.17632/rg4pd9c89j.1
Contributor:
Khalaf Kridin

Description

Supplementary tables for the research letter published in the International Journal of Dermatology

Files

Institutions

  • Bar-Ilan University

Categories

Dermatology, Epidemiology

Licence